Topical ONYX-015 in the treatment of premalignant oral dysplasia: Another role for the cold virus? Journal Article

  

Authors:	Ganly, I.; Singh, B.
Article Title:	Topical ONYX-015 in the treatment of premalignant oral dysplasia: Another role for the cold virus?
Keywords:	cancer survival; clinical trial; cisplatin; fluorouracil; cancer combination chemotherapy; drug efficacy; drug potentiation; drug withdrawal; note; drug megadose; follow up; controlled clinical trial; randomized controlled trial; administration, topical; editorial; antineoplastic activity; drug selectivity; oncolytic virotherapy; alpha tocopherol; isotretinoin; laser surgery; photodynamic therapy; mouth neoplasms; mouth cancer; viral vaccines; adenoviridae; onyx 015; precancerous conditions; mouth hygiene; adenovirus; mouthwashes; conjunctivitis; precancer; mouth tumor; topical drug administration; virus vaccine; humans; human; priority journal; xeroderma
Journal Title:	Journal of Clinical Oncology
Volume:	21
Issue:	24
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2003-12-15
Start Page:	4476
End Page:	4478
Language:	English
DOI:	10.1200/jco.2003.08.997
PUBMED:	14597746
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-1542648391&partnerID=40&md5=ef8b577ee610c6946d2f0246d7f399cd
Notes:	Export Date: 25 September 2014 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/60916